Longitudinal assessment of cardiac diastolic function in HIV-infected patients (Q44793892)

6 December 2017

Longitudinal assessment of cardiac diastolic function in HIV-infected patients (English)

1 reference

6 December 2017

1 reference

J M Blaylock

1

1 reference

6 December 2017

D K Byers

2

1 reference

6 December 2017

B T Gibbs

3

1 reference

6 December 2017

G Nayak

4

1 reference

6 December 2017

M Ferguson

5

1 reference

6 December 2017

D R Tribble

6

1 reference

6 December 2017

C Porter

7

1 reference

6 December 2017

C F Decker

8

1 reference

6 December 2017

1 February 2012

1 reference

International Journal of STD & AIDS

6 December 2017

1 reference

6 December 2017

23

1 reference

6 December 2017

2

1 reference

6 December 2017

105-110

1 reference

Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies

6 December 2017

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.011099

Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.011099

Impact of HIV infection and HAART on serum lipids in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.011099

Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.011099

Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.011099

Class of Antiretroviral Drugs and the Risk of Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.011099

CD4+ count-guided interruption of antiretroviral treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.011099

Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS Clinical Trials Group) Study 5152s.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.011099

Current update on HIV-associated vascular disease and endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.011099

Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.011099

Impact of HIV infection on diastolic function and left ventricular mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.011099

Prevalence of cardiac diastolic dysfunction in HIV-infected patients: results of the HIV-HEART study

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.011099

Subclinical cardiac abnormalities in human immunodeficiency virus-infected men receiving antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.011099

High Prevalence of Echocardiographic Abnormalities among HIV-infected Persons in the Era of Highly Active Antiretroviral Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.011099

Prevalence of left ventricular diastolic dysfunction in a general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.011099

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.011099

Subjective visual echocardiographic estimate of left ventricular ejection fraction as an alternative to conventional echocardiographic methods: Comparison with contrast angiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.011099

Prediction of Coronary Heart Disease Using Risk Factor Categories

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.011099

Long-term cocaine use is related to cardiac diastolic dysfunction in an African-American population in Baltimore, Maryland

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.011099

A comparison of echocardiographic findings in young adults with cardiomyopathy: with and without a history of methamphetamine abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.011099

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.011099

Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.011099

Risk of myocardial infarction and abacavir therapy: no increased risk across 52 GlaxoSmithKline-sponsored clinical trials in adult subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.011099

Impact of individual antiretroviral drugs on the risk of myocardial infarction in human immunodeficiency virus-infected patients: a case-control study nested within the French Hospital Database on HIV ANRS cohort CO4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.011099

Relationship between inflammatory markers, endothelial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.011099

Endothelial activation markers are linked to HIV status and are independent of antiretroviral therapy and lipoatrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.011099

Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.011099

Determinants of Doppler indexes of left ventricular diastolic function in normal subjects (the Framingham heart study)

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.011099

Trends in prevalence and outcome of heart failure with preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.011099

The development of heart failure in patients with diabetes mellitus and pre-clinical diastolic dysfunction a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.011099

Protease inhibitors and cardiovascular outcomes in patients with HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2011.011099

21 January 2018

Identifiers

DOI

10.1258/IJSA.2011.011099

1 reference

6 December 2017

1 reference